Clinical trial
Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion: A Multicenter Prospective Randomized Controlled Clinical Trial
NCT07668323 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion: A Multicenter Prospective Randomized Controlled Clinical Trial
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- September 19, 2026
- Completion date
- May 31, 2029
- Enrollment
- 372 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ischemic stroke, acute, medium vessel occlusion